GCC2_HUMAN - dbPTM
GCC2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GCC2_HUMAN
UniProt AC Q8IWJ2
Protein Name GRIP and coiled-coil domain-containing protein 2
Gene Name GCC2
Organism Homo sapiens (Human).
Sequence Length 1684
Subcellular Localization Cytoplasm. Golgi apparatus, trans-Golgi network membrane
Peripheral membrane protein.
Protein Description Golgin which probably tethers transport vesicles to the trans-Golgi network (TGN) and regulates vesicular transport between the endosomes and the Golgi. As a RAB9A effector it is involved in recycling of the mannose 6-phosphate receptor from the late endosomes to the TGN. May also play a role in transport between the recycling endosomes and the Golgi. Required for maintenance of the Golgi structure, it is involved in the biogenesis of noncentrosomal, Golgi-associated microtubules through recruitment of CLASP1 and CLASP2..
Protein Sequence MEDLVQDGVASPATPGTGKSKLETLPKEDLIKFAKKQMMLIQKAKSRCTELEKEIEELRSKPVTEGTGDIIKALTERLDALLLEKAETEQQCLSLKKENIKMKQEVEDSVTKMGDAHKELEQSHINYVKEIENLKNELMAVRSKYSEDKANLQKQLEEAMNTQLELSEQLKFQNNSEDNVKKLQEEIEKIRPGFEEQILYLQKQLDATTDEKKETVTQLQNIIEANSQHYQKNINSLQEELLQLKAIHQEEVKELMCQIEASAKEHEAEINKLNELKENLVKQCEASEKNIQKKYECELENLRKATSNANQDNQICSILLQENTFVEQVVNEKVKHLEDTLKELESQHSILKDEVTYMNNLKLKLEMDAQHIKDEFFHEREDLEFKINELLLAKEEQGCVIEKLKSELAGLNKQFCYTVEQHNREVQSLKEQHQKEISELNETFLSDSEKEKLTLMFEIQGLKEQCENLQQEKQEAILNYESLREIMEILQTELGESAGKISQEFESMKQQQASDVHELQQKLRTAFTEKDALLETVNRLQGENEKLLSQQELVPELENTIKNLQEKNGVYLLSLSQRDTMLKELEGKINSLTEEKDDFINKLKNSHEEMDNFHKKCEREERLILELGKKVEQTIQYNSELEQKVNELTGGLEETLKEKDQNDQKLEKLMVQMKVLSEDKEVLSAEVKSLYEENNKLSSEKKQLSRDLEVFLSQKEDVILKEHITQLEKKLQLMVEEQDNLNKLLENEQVQKLFVKTQLYGFLKEMGSEVSEDSEEKDVVNVLQAVGESLAKINEEKCNLAFQRDEKVLELEKEIKCLQEESVVQCEELKSLLRDYEQEKVLLRKELEEIQSEKEALQSDLLEMKNANEKTRLENQNLLIQVEEVSQTCSKSEIHNEKEKCFIKEHENLKPLLEQKELRDRRAELILLKDSLAKSPSVKNDPLSSVKELEEKIENLEKECKEKEEKINKIKLVAVKAKKELDSSRKETQTVKEELESLRSEKDQLSASMRDLIQGAESYKNLLLEYEKQSEQLDVEKERANNFEHRIEDLTRQLRNSTLQCETINSDNEDLLARIETLQSNAKLLEVQILEVQRAKAMVDKELEAEKLQKEQKIKEHATTVNELEELQVQLQKQKKQLQKTMQELELVKKDAQQTTLMNMEIADYERLMKELNQKLTNKNNKIEDLEQEIKIQKQKQETLQEEITSLQSSVQQYEEKNTKIKQLLVKTKKELADSKQAETDHLILQASLKGELEASQQQVEVYKIQLAEITSEKHKIHEHLKTSAEQHQRTLSAYQQRVTALQEECRAAKAEQATVTSEFESYKVRVHNVLKQQKNKSMSQAETEGAKQEREHLEMLIDQLKIKLQDSQNNLQINVSELQTLQSEHDTLLERHNKMLQETVSKEAELREKLCSIQSENMMMKSEHTQTVSQLTSQNEVLRNSFRDQVRHLQEEHRKTVETLQQQLSKMEAQLFQLKNEPTTRSPVSSQQSLKNLRERRNTDLPLLDMHTVTREEGEGMETTDTESVSSASTYTQSLEQLLNSPETKLEPPLWHAEFTKEELVQKLSSTTKSADHLNGLLRETEATNAILMEQIKLLKSEIRRLERNQEREKSAANLEYLKNVLLQFIFLKPGSERERLLPVINTMLQLSPEEKGKLAAVAQGEEENASRSSGWASYLHSWSGLR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEDLVQDG
-------CHHHHCCC
40.2620068231
11PhosphorylationLVQDGVASPATPGTG
HHCCCCCCCCCCCCC
16.8022199227
11 (in isoform 3)Phosphorylation-16.8025159151
14PhosphorylationDGVASPATPGTGKSK
CCCCCCCCCCCCCHH
26.1522199227
14 (in isoform 3)Phosphorylation-26.1525159151
17PhosphorylationASPATPGTGKSKLET
CCCCCCCCCCHHHCC
42.5122199227
32UbiquitinationLPKEDLIKFAKKQMM
CCHHHHHHHHHHHHH
46.7121890473
36MalonylationDLIKFAKKQMMLIQK
HHHHHHHHHHHHHHH
39.7426320211
36UbiquitinationDLIKFAKKQMMLIQK
HHHHHHHHHHHHHHH
39.74-
53UbiquitinationSRCTELEKEIEELRS
HHHHHHHHHHHHHHC
76.30-
72UbiquitinationEGTGDIIKALTERLD
CCHHHHHHHHHHHHH
37.362189047
88PhosphorylationLLLEKAETEQQCLSL
HHHHHHHHHHHHHHH
43.9130206219
94PhosphorylationETEQQCLSLKKENIK
HHHHHHHHHHHHCCC
45.8530206219
962-HydroxyisobutyrylationEQQCLSLKKENIKMK
HHHHHHHHHHCCCCC
55.45-
109PhosphorylationMKQEVEDSVTKMGDA
CCHHHHHHHHHHHHH
20.4129978859
111PhosphorylationQEVEDSVTKMGDAHK
HHHHHHHHHHHHHHH
21.1829978859
1352-HydroxyisobutyrylationVKEIENLKNELMAVR
HHHHHHHHHHHHHHH
61.02-
143PhosphorylationNELMAVRSKYSEDKA
HHHHHHHHHHHHHHH
29.3720068231
1492-HydroxyisobutyrylationRSKYSEDKANLQKQL
HHHHHHHHHHHHHHH
34.81-
236PhosphorylationHYQKNINSLQEELLQ
HHHHHHHHHHHHHHH
27.8623663014
245UbiquitinationQEELLQLKAIHQEEV
HHHHHHHHHHCHHHH
32.13-
272UbiquitinationEHEAEINKLNELKEN
HHHHHHHHHHHHHHH
59.35-
287PhosphorylationLVKQCEASEKNIQKK
HHHHHHHHHHHHHHH
27.1517192257
294AcetylationSEKNIQKKYECELEN
HHHHHHHHHHHHHHH
29.8827452117
295PhosphorylationEKNIQKKYECELENL
HHHHHHHHHHHHHHH
32.6127642862
349PhosphorylationKELESQHSILKDEVT
HHHHHHHHHHHHHHH
23.2124719451
403AcetylationEQGCVIEKLKSELAG
HCCCHHHHHHHHHCC
50.5223749302
417PhosphorylationGLNKQFCYTVEQHNR
CCCHHHHHHHHHHHH
18.34-
443PhosphorylationEISELNETFLSDSEK
HHHHHHHHHCCHHHH
28.8929523821
446PhosphorylationELNETFLSDSEKEKL
HHHHHHCCHHHHHHH
34.5926657352
448PhosphorylationNETFLSDSEKEKLTL
HHHHCCHHHHHHHHH
47.3829523821
450UbiquitinationTFLSDSEKEKLTLMF
HHCCHHHHHHHHHHH
65.19-
480PhosphorylationKQEAILNYESLREIM
HHHHHHCHHHHHHHH
11.9323403867
482PhosphorylationEAILNYESLREIMEI
HHHHCHHHHHHHHHH
23.5130243723
492PhosphorylationEIMEILQTELGESAG
HHHHHHHHHHHHHHH
29.72-
497PhosphorylationLQTELGESAGKISQE
HHHHHHHHHHHHHHH
40.2923403867
500UbiquitinationELGESAGKISQEFES
HHHHHHHHHHHHHHH
38.61-
507PhosphorylationKISQEFESMKQQQAS
HHHHHHHHHHHHHCH
36.2828555341
522UbiquitinationDVHELQQKLRTAFTE
HHHHHHHHHHHHHHH
27.29-
525PhosphorylationELQQKLRTAFTEKDA
HHHHHHHHHHHHHHH
36.2429083192
528PhosphorylationQKLRTAFTEKDALLE
HHHHHHHHHHHHHHH
39.3929083192
530UbiquitinationLRTAFTEKDALLETV
HHHHHHHHHHHHHHH
45.29-
536PhosphorylationEKDALLETVNRLQGE
HHHHHHHHHHHHCCH
24.0529083192
571PhosphorylationLQEKNGVYLLSLSQR
HHHHCCEEEEEHHHH
11.8825219547
574PhosphorylationKNGVYLLSLSQRDTM
HCCEEEEEHHHHHHH
24.3126074081
576PhosphorylationGVYLLSLSQRDTMLK
CEEEEEHHHHHHHHH
21.5726074081
580PhosphorylationLSLSQRDTMLKELEG
EEHHHHHHHHHHHHH
26.9626074081
591PhosphorylationELEGKINSLTEEKDD
HHHHHHHCCCHHHHH
39.8923663014
593PhosphorylationEGKINSLTEEKDDFI
HHHHHCCCHHHHHHH
41.7525219547
5962-HydroxyisobutyrylationINSLTEEKDDFINKL
HHCCCHHHHHHHHHH
57.26-
606PhosphorylationFINKLKNSHEEMDNF
HHHHHHCCHHHHHHH
30.59-
677PhosphorylationMVQMKVLSEDKEVLS
HHHHHHHCCCHHHHH
46.8930108239
6802-HydroxyisobutyrylationMKVLSEDKEVLSAEV
HHHHCCCHHHHHHHH
45.75-
689PhosphorylationVLSAEVKSLYEENNK
HHHHHHHHHHHHHCC
41.1624961811
698PhosphorylationYEENNKLSSEKKQLS
HHHHCCCCHHHHHHH
37.7521406692
699PhosphorylationEENNKLSSEKKQLSR
HHHCCCCHHHHHHHH
64.9621406692
713PhosphorylationRDLEVFLSQKEDVIL
HHHHHHHHHHHHHHH
27.9521406692
752UbiquitinationLENEQVQKLFVKTQL
HCHHHHHHHHHHHHH
45.06-
760PhosphorylationLFVKTQLYGFLKEMG
HHHHHHHHHHHHHHC
8.9427642862
792UbiquitinationAVGESLAKINEEKCN
HHHHHHHHHCHHHHC
51.89-
807UbiquitinationLAFQRDEKVLELEKE
HHCCCCHHHHHHHHH
57.31-
813UbiquitinationEKVLELEKEIKCLQE
HHHHHHHHHHHHHHH
76.88-
816UbiquitinationLELEKEIKCLQEESV
HHHHHHHHHHHHCCC
29.95-
830UbiquitinationVVQCEELKSLLRDYE
CCCHHHHHHHHCHHH
42.19-
831PhosphorylationVQCEELKSLLRDYEQ
CCHHHHHHHHCHHHH
45.3124719451
840UbiquitinationLRDYEQEKVLLRKEL
HCHHHHHHHHHHHHH
37.57-
892PhosphorylationVSQTCSKSEIHNEKE
HHHHCCHHHHCCCHH
26.0328258704
931PhosphorylationELILLKDSLAKSPSV
HHHHHHHHHCCCCCC
28.7428555341
935PhosphorylationLKDSLAKSPSVKNDP
HHHHHCCCCCCCCCC
19.4629496963
937PhosphorylationDSLAKSPSVKNDPLS
HHHCCCCCCCCCCCH
53.4618491316
944PhosphorylationSVKNDPLSSVKELEE
CCCCCCCHHHHHHHH
38.1723532336
945PhosphorylationVKNDPLSSVKELEEK
CCCCCCHHHHHHHHH
44.9120068231
952AcetylationSVKELEEKIENLEKE
HHHHHHHHHHHHHHH
46.0420167786
958AcetylationEKIENLEKECKEKEE
HHHHHHHHHHHHHHH
72.1320167786
971AcetylationEEKINKIKLVAVKAK
HHHHHHHHHEEHHHH
38.2225953088
971MalonylationEEKINKIKLVAVKAK
HHHHHHHHHEEHHHH
38.2226320211
988PhosphorylationLDSSRKETQTVKEEL
HCCCCHHHHHHHHHH
32.3518491316
10022-HydroxyisobutyrylationLESLRSEKDQLSASM
HHHHHCHHHHHHHHH
52.61-
1010MethylationDQLSASMRDLIQGAE
HHHHHHHHHHHHHHH
32.84-
1018PhosphorylationDLIQGAESYKNLLLE
HHHHHHHHHHHHHHH
40.6530576142
1019PhosphorylationLIQGAESYKNLLLEY
HHHHHHHHHHHHHHH
8.7330576142
1030PhosphorylationLLEYEKQSEQLDVEK
HHHHHHHHHHCCHHH
38.0820873877
1077PhosphorylationDLLARIETLQSNAKL
HHHHHHHHHHHCCCC
27.9421406692
1080PhosphorylationARIETLQSNAKLLEV
HHHHHHHHCCCCHHH
41.7021406692
1098SulfoxidationEVQRAKAMVDKELEA
HHHHHHHHHCHHHHH
3.8421406390
1141PhosphorylationQKKQLQKTMQELELV
HHHHHHHHHHHHHHH
15.8921082442
1155PhosphorylationVKKDAQQTTLMNMEI
HHHHHHHHHHHHHHH
15.1526552605
1156PhosphorylationKKDAQQTTLMNMEIA
HHHHHHHHHHHHHHH
21.4826552605
1165PhosphorylationMNMEIADYERLMKEL
HHHHHHHHHHHHHHH
8.2326552605
1222MalonylationEEKNTKIKQLLVKTK
HHHHHHHHHHHHHCH
36.1326320211
1227AcetylationKIKQLLVKTKKELAD
HHHHHHHHCHHHHCC
55.3825953088
1274AcetylationLAEITSEKHKIHEHL
HHHHHCCHHHHHHHH
50.3825953088
1382PhosphorylationNVSELQTLQSEHDTL
EHHHHHHHHHHHHHH
3.2118669648
1410AcetylationKEAELREKLCSIQSE
HHHHHHHHHHHHHHH
48.6519819133
1416PhosphorylationEKLCSIQSENMMMKS
HHHHHHHHHCCCCCC
29.3025954137
1423PhosphorylationSENMMMKSEHTQTVS
HHCCCCCCCHHHHHH
19.4025954137
1428PhosphorylationMKSEHTQTVSQLTSQ
CCCCHHHHHHHHHHH
24.2325954137
1430PhosphorylationSEHTQTVSQLTSQNE
CCHHHHHHHHHHHHH
23.9025954137
1433PhosphorylationTQTVSQLTSQNEVLR
HHHHHHHHHHHHHHH
22.1925954137
1434PhosphorylationQTVSQLTSQNEVLRN
HHHHHHHHHHHHHHH
39.3325954137
1441PhosphorylationSQNEVLRNSFRDQVR
HHHHHHHHHHHHHHH
41.1418669648
1456UbiquitinationHLQEEHRKTVETLQQ
HHHHHHHHHHHHHHH
59.85-
1480PhosphorylationFQLKNEPTTRSPVSS
HHCCCCCCCCCCCCC
28.7626657352
1481PhosphorylationQLKNEPTTRSPVSSQ
HCCCCCCCCCCCCCH
39.6125159151
1483PhosphorylationKNEPTTRSPVSSQQS
CCCCCCCCCCCCHHH
27.7925159151
1486PhosphorylationPTTRSPVSSQQSLKN
CCCCCCCCCHHHHHH
26.3028450419
1487PhosphorylationTTRSPVSSQQSLKNL
CCCCCCCCHHHHHHH
32.2625159151
1490PhosphorylationSPVSSQQSLKNLRER
CCCCCHHHHHHHHHH
33.4025159151
1492UbiquitinationVSSQQSLKNLRERRN
CCCHHHHHHHHHHCC
60.22-
1500PhosphorylationNLRERRNTDLPLLDM
HHHHHCCCCCCEEEC
36.7825849741
1509PhosphorylationLPLLDMHTVTREEGE
CCEEECEEEECCCCC
19.55-
1542PhosphorylationSLEQLLNSPETKLEP
HHHHHHCCCCCCCCC
24.8829496963
1545PhosphorylationQLLNSPETKLEPPLW
HHHCCCCCCCCCCCC
44.2926074081
1548PhosphorylationNSPETKLEPPLWHAE
CCCCCCCCCCCCCCC
46.5618669648
1558UbiquitinationLWHAEFTKEELVQKL
CCCCCCCHHHHHHHH
55.29-
1564UbiquitinationTKEELVQKLSSTTKS
CHHHHHHHHHHCCCC
42.74-
1566PhosphorylationEELVQKLSSTTKSAD
HHHHHHHHHCCCCHH
32.4530108239
1567PhosphorylationELVQKLSSTTKSADH
HHHHHHHHCCCCHHH
51.0030108239
1568PhosphorylationLVQKLSSTTKSADHL
HHHHHHHCCCCHHHH
34.5630108239
1569PhosphorylationVQKLSSTTKSADHLN
HHHHHHCCCCHHHHH
25.5830108239
1570UbiquitinationQKLSSTTKSADHLNG
HHHHHCCCCHHHHHH
43.67-
1571PhosphorylationKLSSTTKSADHLNGL
HHHHCCCCHHHHHHH
36.5225159151
1590SulfoxidationEATNAILMEQIKLLK
HHHHHHHHHHHHHHH
2.6621406390
1594UbiquitinationAILMEQIKLLKSEIR
HHHHHHHHHHHHHHH
47.68-
1597UbiquitinationMEQIKLLKSEIRRLE
HHHHHHHHHHHHHHH
57.38-
1611UbiquitinationERNQEREKSAANLEY
HHHHHHHHHHHHHHH
52.17-
1612PhosphorylationRNQEREKSAANLEYL
HHHHHHHHHHHHHHH
28.06-
1618PhosphorylationKSAANLEYLKNVLLQ
HHHHHHHHHHHHHHH
26.5822817900
1630UbiquitinationLLQFIFLKPGSERER
HHHHHHCCCCCHHHH
36.26-
1644PhosphorylationRLLPVINTMLQLSPE
HHHHHHHHHHHCCHH
14.2427251275
1649PhosphorylationINTMLQLSPEEKGKL
HHHHHHCCHHHHCHH
19.8022617229
1668PhosphorylationQGEEENASRSSGWAS
CCCHHCCCCCCCHHH
44.2523663014
1670PhosphorylationEEENASRSSGWASYL
CHHCCCCCCCHHHHH
30.61-
1671PhosphorylationEENASRSSGWASYLH
HHCCCCCCCHHHHHH
36.9323663014

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of GCC2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of GCC2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GCC2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of GCC2_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of GCC2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1483; SER-1542 ANDSER-1649, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287 AND SER-1649, ANDMASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1483, AND MASSSPECTROMETRY.

TOP